Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP.
Onida F, Sbianchi G, Radujkovic A, Sockel K, Kröger N, Sierra J, Socié G, Cornelissen J, Poiré X, Raida L, Bourhis JH, Finke J, Passweg J, Salmenniemi U, Schouten HC, Beguin Y, Martin S, Deconinck E, Ganser A, Zver S, Lioure B, Rohini R, Koster L, Hayden P, Iacobelli S, Robin M, Yakoub-Agha I. Onida F, et al. Among authors: raida l. Bone Marrow Transplant. 2022 Jun;57(6):896-902. doi: 10.1038/s41409-021-01555-9. Epub 2022 Mar 29. Bone Marrow Transplant. 2022. PMID: 35352038 Free article.
Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT.
van Gelder M, Ziagkos D, de Wreede L, van Biezen A, Dreger P, Gramatzki M, Stelljes M, Andersen NS, Schaap N, Vitek A, Beelen D, Lindström V, Finke J, Passweg J, Eder M, Machaczka M, Delgado J, Krüger W, Raida L, Socié G, Jindra P, Afanasyev B, Wagner E, Chalandon Y, Henseler A, Schoenland S, Kröger N, Schetelig J; CLL Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. van Gelder M, et al. Among authors: raida l. Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10):667-675.e2. doi: 10.1016/j.clml.2017.06.007. Epub 2017 Jun 17. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28694085
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.
Hernández-Boluda JC, Eikema DJ, Koster L, Kröger N, Robin M, de Witte M, Finke J, Finazzi MC, Broers A, Raida L, Schaap N, Chiusolo P, Verbeek M, Hazenberg CLE, Halaburda K, Kulagin A, Labussière-Wallet H, Gedde-Dahl T, Rabitsch W, Raj K, Drozd-Sokolowska J, Battipaglia G, Polverelli N, Czerw T, Yakoub-Agha I, McLornan DP. Hernández-Boluda JC, et al. Among authors: raida l. Bone Marrow Transplant. 2023 Dec;58(12):1357-1367. doi: 10.1038/s41409-023-02094-1. Epub 2023 Sep 7. Bone Marrow Transplant. 2023. PMID: 37679647
Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, Indrak K, Papajik T. Prochazka V, et al. Among authors: raida l. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):63-6. doi: 10.5507/bp.2009.011. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365529 Free article.
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T, Pikalova Z, Raida L, Skoumalova I, Vondrakova J, Faber E, Prochazka V, Kubova Z, Kucerova L, Pavlik T, Dusek L, Indrak K. Papajik T, et al. Among authors: raida l. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Sep;153(3):211-4. doi: 10.5507/bp.2009.035. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19851434 Free article.
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
Raida L, Tucek P, Faber E, Vondrakova J, Rusinakova Z, Skoumalova I, Hubacek J, Jarosova M, Katrincsakova B, Pikalova Z, Kurfurst P, Indrak K. Raida L, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):327-32. doi: 10.5507/bp.2011.040. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 22336644
The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czech acute leukaemia clinical register (alert).
Jindra P, Muzik J, Indrak K, Zak P, Sabty FA, Kozak T, Cetkovsky P, Karas VK, Raida L, Szotkowski T. Jindra P, et al. Among authors: raida l. Neoplasma. 2013;60(5):576-83. doi: 10.4149/neo_2013_075. Neoplasma. 2013. PMID: 23790178
The availability of HEPA-filtered rooms and the incidence of pneumonia in patients after haematopoietic stem cell transplantation (HSCT): results from a prospective, multicentre, eastern European study.
Vokurka S, Bystrická E, Svoboda T, Škoda Gorican IK, Sever M, Mazur E, Kopinska A, Pavlicová V, Mocanu O, Tanase A, Ghelase R, Zítková M, Labudíková M, Raida L, Hrabánková-Navrátilová D, Bocková J. Vokurka S, et al. Among authors: raida l. J Clin Nurs. 2014 Jun;23(11-12):1648-52. doi: 10.1111/jocn.12286. Epub 2013 Dec 20. J Clin Nurs. 2014. PMID: 24354726
74 results